Hjem › Type 2-diabetes
Type 2-diabetes kliniske forsøg rekrutterer i USA
240 studier for Type 2-diabetes rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL24 studier
- Boston, MA20 studier
- Miami, FL19 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- Atlanta, GA17 studier
- San Diego, CA17 studier
- Los Angeles, CA16 studier
- New York City, NY16 studier
- Birmingham, AL16 studier
- Philadelphia, PA15 studier
- Arlington, VA15 studier
- Jacksonville, FL15 studier
- Havelock, NC13 studier
- Cincinnati, OH12 studier
- Washington, DC12 studier
- Austin, TX12 studier
- Indianapolis, IN12 studier
- Aurora, CO11 studier
- Durham, NC11 studier
- Long Beach, CA11 studier
- Kansas City, MO11 studier
- Albuquerque, NM11 studier
- Salt Lake City, UT11 studier
- Omaha, NE11 studier
- Ann Arbor, MI10 studier
- Baltimore, MD10 studier
- Hialeah, FL10 studier
- Little Rock, AR10 studier
- Oklahoma City, OK10 studier
- Wichita, KS10 studier
- Pittsburgh, PA10 studier
- Deltona, FL10 studier
- Tucson, AZ10 studier
- New Haven, CT10 studier
- Concord, CA10 studier
Efter delstat
- Alabama22 studier
- Arizona22 studier
- Arkansas11 studier
- Californien67 studier
- Colorado16 studier
- Connecticut14 studier
- District of Columbia7 studier
- Florida48 studier
- Georgia34 studier
- Hawaii7 studier
- Idaho12 studier
- Illinois30 studier
- Indiana18 studier
- Iowa10 studier
- Kansas15 studier
- Kentucky12 studier
- Louisiana15 studier
- Maryland26 studier
- Massachusetts29 studier
- Michigan27 studier
- Minnesota17 studier
- Mississippi9 studier
- Missouri20 studier
- Montana4 studier
- Nebraska14 studier
- Nevada18 studier
- New Jersey15 studier
- New Mexico12 studier
- New York33 studier
- North Carolina36 studier
- North Dakota6 studier
- Ohio41 studier
- Oklahoma13 studier
- Oregon7 studier
- Pennsylvania30 studier
- Rhode Island3 studier
- South Carolina20 studier
- South Dakota3 studier
- Tennessee18 studier
- Texas58 studier
- Utah19 studier
- Virginia26 studier
- Washington20 studier
- West Virginia7 studier
- Wisconsin9 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT05279729Efficacy of Using Mobile Health Applications for Health
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT05589155Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Rekrutterer
Alder 18 til 60 · Alle køn · Opdateret 2. okt. 2026 · NCT07641361Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06906627A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07564414Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Rekrutterer
Alder 18 og opefter · Kvinder · Opdateret 29. sep. 2026 · NCT05909046NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Rekrutterer
Alle aldre · Alle køn · Opdateret 29. sep. 2026 · NCT06593327A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 29. sep. 2026 · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06836479Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07399678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07776509ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Rekrutterer
Alder 8 til 21 · Alle køn · Opdateret 23. sep. 2026 · NCT05463289A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 22. sep. 2026 · NCT02969798Phenotyping Genetic Risk for Type 2 Diabetes
RekruttererFrivillige med god helbredstilstand velkomne
Alder 10 til 70 · Alle køn · Opdateret 21. sep. 2026 · NCT04024631Improving the Collaborative Health of Adult Dyads
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05370014Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 til 45 · Alle køn · Opdateret 18. sep. 2026 · NCT07494084Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.